World Gene Amplification Technologies Market

Home >
Life Sciences >
Biotechnology >
World Gene Amplification Technologies Market

Report price : $ 3 950
Publication date : October 2008
Length : 282 pages

This report analyzes the worldwide markets for Gene Amplification Technologies in Millions of US$. The major product segments analyzed are Polymerase Chain Reaction, and Other Gene Amplification Technologies. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2015. The report profiles 93 companies including many key and niche players worldwide such as Abbott Laboratories, Applied Biosystems, Becton, Dickinson and Company, bioMerieux, Bio-Rad Laboratories, Cepheid, QIAGEN N.V, Roche Diagnostics, Rubicon Genomics, and Takara Bio, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

GENE AMPLIFICATION TECHNOLOGIES MCP-1102
A GLOBAL STRATEGIC BUSINESS REPORT

CONTENTS

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-2
Quantitative Techniques & Analytics I-2
Product Definitions and Scope of Study I-3
Definitions I-3
Polymerase Chain Reaction I-3
Other Gene Amplification Technologies I-3

II. EXECUTIVE SUMMARY

1. Industry Overview II-1
PCR Dominates Amplification Technologies II-1
Miniaturization - The Next Big Focus II-1
Critical in Diagnostic Procedures II-1
Leading Players II-2

2. Technology Overview II-3
Definition of Gene Amplification II-3
Target vs. Signal Amplification II-3
Available Types of Gene Amplification Technologies II-3
Polymerase Chain Reaction II-3
Reagents and Equipment required for PCR II-4
Reaction Steps II-4
Denaturation II-4
Annealing II-4
Extension II-4
Detection of Amplified Product/DNA II-5
(Q&Q) PCR II-5
Reverse Transcriptase PCR (RT-PCR) II-5
Alternative Technologies to PCR II-6
OmniPlex II-6
Strand Displacement Amplification II-6
Ligase Chain Reaction II-7
LCR Involves a Cyclic Two-Step Reaction II-7
Gene Amplification Technology (GAT) II-7
Hybrid Capture II-7
Isothermal DNA Amplification Techniques II-7
Rolling circle Amplification in Diagnostics II-7
Ican Isothermal Gene Amplification Technology II-8
Other Amplification Technologies II-8
Signal Amplification Technology II-8
Transcription Mediated Amplification II-8
DNA cleavage-based signal amplification II-9
Ramification Amplification Method II-9

3. End Use Market Analysis II-10
Medical and Diagnostics II-10
Role of Amplification Technology in Diagnostics of Infectious
Diseases II-10
Diagnosis of Infectious Diseases by PCR II-10
Detection of Antimicrobial Resistance II-11
PCR Based Nucleic Acid Amplification for Detection of
Antimicrobial Agents II-11
Nucleic Acid Amplification Testing (NAT) II-11
Nucleic Acid Amplification Methods II-11 DNA Amplification
Technology in the Diagnosis of Infectious Diseases II-12
Forensic and Paternity II-12
Food Safety II-12

4. Product Innovations/Launches II-13
Bio-Rad Launches New CFX96 PCR Detection System II-13
Roche Introduces Genome Sequencer FLX System II-13
QIAGEN Launches TopTaq DNA Polymerase II-13
Applied Biosystems Introduces TaqMan Array Human MicroRNA Panel II-13
Spartan Introduces Spartan DX II-14
Applied Biosystems Launches Forensic Tools II-14
Applied Biosystems Introduces StepOne Real-Time PCR System II-15
Sigma-Aldrich Unveils GenomePlex Tissue Whole Genome
Amplification Kit II-15
QIAGEN Rolls Out Wide RNAi and SYBR® Green-based RT- PCR II-15
Applied Biosystems Launches 7500 Fast Real-Time PCR System II-15
Applied Biosystems Launches 9800 Fast PCR System II-16
7900HT Fast Real-Time PCR System from Applied Biosystems II-16
Enzo Life Sciences Introduces New Advanced Amplification
Technology II-16
Applied Biosystems Unveils AmpFSTR® Yfiler™ PCR Amplification Kit II-16
Amersham Launches GenomiPhi II-17
Rubicon Genomics Launches GenomePlex WGA II-17
Agilent Introduces Amplification Kit II-17
Linden Introduces Snapshot mRNA II-17
Rubicon Launches OmniPlex™ II-18

5. Recent Industry Activity II-19
Hologic Acquires Third Wave Technologies II-19
BIOTECON Acquires Roche's Technology License II-19
QIAGEN Signs a Global Licensing Agreement with BioHelix II-19
BioTrove and Gene Express Receive NIH Grant for Innovative
Bio-experimentation II-19
SuperArray Bioscience Inks License Agreement with Applied
Biosystems II-20
Merck Capital Takes Over Minority Interest in High Throughput
Genomics II-20
NuGEN Enters into a Service Agreement with ExonHit II-20
Qiagen Enters into License Agreements with Roche and Ortho-
Clinical II-21
Agilent Takes Over Stratagene II-21
Eiken Chemical Inks Licensing Agreement with Meridian Bioscience II-21
Sigma-Aldrich Acquires JRH II-22
Sigma-Aldrich Snaps Up Proligo II-22
Beckman to Acquire Agencourt II-22
Roche Diagnostics and Applera Corporation Expand PCR Licensing
Program II-22
Mount and Hamilton Receive Patent II-22
Invitrogen Bags License from Applied Biosystems II-22
OriGene to Access TrueClone II-22
Orchid BioSciences to Turn into Orchid Cellmark II-23
QIAGEN Purchases Assets of Molecular Staging II-23
Cepheid, Applied Biosystems and Celera Diagnostics Sign Patent
License Agreement II-23
Abbott Enters into Agreement with BioGenex II-23
Roche Inks Licensing Agreement with Incyte Corp II-23
Rubicon Genomics Signs Licensing Agreement with Sigma-Aldrich II-24
BioMérieux Teams-up with Cepheid II-24
Molecular Staging Collaborates with Eli Lilly II-24
Pacific Biometrics Inc. Receives Gene Amplification Patent II-24
Rubicon Introduces Service for Genome Amplification II-24
Takara Obtains Patent for New Amplification Method II-24

6. Focus on Select Global Players II-25
Abbott Laboratories (US) II-25
Applied Biosystems (US) II-25
Becton, Dickinson and Company (US) II-25
bioMérieux (France) II-26
Bio-Rad Laboratories (US) II-26
Cepheid (US) II-26
QIAGEN N.V (The Netherlands) II-26
Roche Diagnostics (Switzerland) II-27
Rubicon Genomics (US) II-27
Takara Bio, Inc. II-27

7. Global Market Perspective II-28
Table 1: World Recent Past, Current & Future Market Analysis
for Gene Amplification Technologies by Geographic Region - US,
Canada, Japan, Europe, and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2000 through 2010 (includes corresponding Graph/Chart) II-28

Table 2: World Long-term Projections for Gene Amplification
Technologies by Geographic Region - US, Canada, Japan, Europe,
and Rest of World Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2011 through 2015
(includes corresponding Graph/Chart) II-29

Table 3: World 10-Year Perspective for Gene Amplification
Technologies by Geographic Region - Percentage Breakdown of
Dollar Sales for US, Canada, Japan, Europe, and Rest of World
Markets for Years 2003, 2008 & 2012 (includes corresponding
Graph/Chart) II-30

Table 4: World Recent Past, Current & Future Market Analysis
for Polymerase Chain Reaction (PCR) by Geographic Region - US,
Canada, Japan, Europe, and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2000 through 2010 (includes corresponding Graph/Chart) II-31

Table 5: World Long-term Projections for Polymerase Chain
Reaction (PCR) by Geographic Region - US, Canada, Japan,
Europe, and Rest of World Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2011 through
2015 (includes corresponding Graph/Chart) II-32

Table 6: World 10-Year Perspective for Polymerase Chain
Reaction (PCR) by Geographic Region - Percentage Breakdown of
Dollar Sales for US, Canada, Japan, Europe, and Rest of World
Markets for Years 2003, 2008 & 2012 (includes corresponding
Graph/Chart) II-33

Table 7: World Recent Past, Current & Future Market Analysis
for Other Gene Amplification Technologies by Geographic Region
- US, Canada, Japan, Europe, and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) II-34

Table 8: World Long-term Projections for Other Gene
Amplification Technologies by Geographic Region - US, Canada,
Japan, Europe, and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2011 through 2015 (includes corresponding Graph/Chart) II-35

Table 9: World 10-Year Perspective for Other Gene
Amplification Technologies by Geographic Region - Percentage
Breakdown of Dollar Sales for US, Canada, Japan, Europe, and
Rest of World Markets for Years 2003, 2008 & 2012 (includes
corresponding Graph/Chart) II-36

III. MARKET

1. The United States III-1
A.Market Analysis III-1
Product Launches III-1
Strategic Corporate Developments III-4
Key Players III-8
Abbott Laboratories III-8
Applied Biosystems III-9
Bio-Rad Laboratories III-9
Cepheid III-9
Rubicon Genomics III-9
B.Market Analytics III-10
Table 10: US Recent Past, Current & Future Analysis for Gene
Amplification Technologies by Segment - Polymerase Chain
Reaction (PCR) and Other Gene Amplification Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) III-10

Table 11: US Long-term Projections for Gene Amplification
Technologies by Segment - Polymerase Chain Reaction (PCR)
and Other Gene Amplification Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2011
through 2015 (includes corresponding Graph/Chart) III-11

Table 12: US 10-Year Perspective for Gene Amplification
Technologies by Segment - Percentage Breakdown of Dollar
Sales for Polymerase Chain Reaction (PCR) and Other Gene
Amplification Markets for 2003, 2008 & 2012 III-11

2. Canada III-12
A.Market Analysis III-12
Strategic Corporate Developments III-12
B.Market Analytics III-13
Table 13: Canadian Recent Past, Current & Future Analysis
for Gene Amplification Technologies by Segment - Polymerase
Chain Reaction (PCR) and Other Gene Amplification Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) III-13

Table 14: Canadian Long-term Projections for Gene
Amplification Technologies by Segment - Polymerase Chain
Reaction (PCR) and Other Gene Amplification Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2011 through 2015 (includes corresponding
Graph/Chart) III-14

Table 15: Canadian 10-Year Perspective for Gene
Amplification Technologies by Segment - Percentage Breakdown
of Dollar Sales for Polymerase Chain Reaction (PCR) and
Other Gene Amplification Markets for 2003, 2008 & 2012 III-14

3. Japan III-15
A.Market Analysis III-15
Key Player III-15
Takara Bio, Inc. III-15
B.Market Analytics III-16
Table 16: Japanese Recent Past, Current & Future Analysis
for Gene Amplification Technologies by Segment - Polymerase
Chain Reaction (PCR) and Other Gene Amplification Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) III-16

Table 17: Japanese Long-term Projections for Gene
Amplification Technologies by Segment - Polymerase Chain
Reaction (PCR) and Other Gene Amplification Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2011 through 2015 (includes corresponding
Graph/Chart) III-17

Table 18: Japanese 10-Year Perspective for Gene
Amplification Technologies by Segment - Percentage Breakdown
of Dollar Sales for Polymerase Chain Reaction (PCR) and
Other Gene Amplification Markets for 2003, 2008 & 2012 III-17

4. Europe III-18
Market Analysis III-18
Table 19: European Recent Past, Current & Future Analysis
for Gene Amplification Technologies by Geographic Region -
France, Germany, UK, Italy, and Rest of Europe Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) III-18

Table 20: European Long-term Projections for Gene
Amplification Technologies by Geographic Region - France,
Germany, UK, Italy, and Rest of Europe Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2011 through 2015 (includes corresponding Graph/Chart) III-19

Table 21: European Recent Past, Current & Future Analysis
for Gene Amplification Technologies by Segment - Polymerase
Chain Reaction (PCR) and Other Gene Amplification Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) III-19

Table 22: European Long-term Projections for Gene
Amplification Technologies by Segment - Polymerase Chain
Reaction (PCR) and Other Gene Amplification Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2011 through 2015 (includes corresponding
Graph/Chart) III-20

Table 23: European 10-Year Perspective for Gene
Amplification Technologies by Geographic Region - Percentage
Breakdown of Dollar Sales for France, Germany, UK, Italy, &
Rest of Europe Markets for Years 2003, 2008 & 2012 (includes
corresponding Graph/Chart) III-21

Table 24: European 10-Year Perspective for Gene
Amplification Technologies by Segment - Percentage Breakdown
of Dollar Sales for Polymerase Chain Reaction (PCR) and
Other Gene Amplification Markets for 2003, 2008 & 2012 III-21

4a. France III-22
A.Market Analysis III-22
Key Player III-22
bioMérieux III-22
B.Market Analytics III-23
Table 25: French Recent Past, Current & Future Analysis for
Gene Amplification Technologies by Segment - Polymerase
Chain Reaction (PCR) and Other Gene Amplification Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) III-23

Table 26: French Long-term Projections for Gene
Amplification Technologies by Segment - Polymerase Chain
Reaction (PCR) and Other Gene Amplification Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2011 through 2015 (includes corresponding
Graph/Chart) III-24

Table 27: French 10-Year Perspective for Gene Amplification
Technologies by Segment - Percentage Breakdown of Dollar
Sales for Polymerase Chain Reaction (PCR) and Other Gene
Amplification Markets for 2003, 2008 & 2012 III-24

4b. Germany III-25
Market Analysis III-25
Table 28: German Recent Past, Current & Future Analysis for
Gene Amplification Technologies by Segment - Polymerase
Chain Reaction (PCR) and Other Gene Amplification Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) III-25

Table 29: German Long-term Projections for Gene
Amplification Technologies by Segment - Polymerase Chain
Reaction (PCR) and Other Gene Amplification Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2011 through 2015 (includes corresponding
Graph/Chart) III-26

Table 30: German 10-Year Perspective for Gene Amplification
Technologies by Segment - Percentage Breakdown of Dollar
Sales for Polymerase Chain Reaction (PCR) and Other Gene
Amplification Markets for 2003, 2008 & 2012 III-26

4c. United Kingdom III-27
Market Analysis III-27
Table 31: UK Recent Past, Current & Future Analysis for Gene
Amplification Technologies by Segment - Polymerase Chain
Reaction (PCR) and Other Gene Amplification Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) III-27

Table 32: UK Long-term Projections for Gene Amplification
Technologies by Segment - Polymerase Chain Reaction (PCR)
and Other Gene Amplification Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2011
through 2015 (includes corresponding Graph/Chart) III-28

Table 33: UK 10-Year Perspective for Gene Amplification
Technologies by Segment - Percentage Breakdown of Dollar
Sales for Polymerase Chain Reaction (PCR) and Other Gene
Amplification Markets for 2003, 2008 & 2012 III-28

4d. Italy III-29
Market Analysis III-29
Table 34: Italian Recent Past, Current & Future Analysis for
Gene Amplification Technologies by Segment - Polymerase
Chain Reaction (PCR) and Other Gene Amplification Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) III-29

Table 35: Italian Long-term Projections for Gene
Amplification Technologies by Segment - Polymerase Chain
Reaction (PCR) and Other Gene Amplification Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2011 through 2015 (includes corresponding
Graph/Chart) III-30

Table 36: Italian 10-Year Perspective for Gene Amplification
Technologies by Segment - Percentage Breakdown of Dollar
Sales for Polymerase Chain Reaction (PCR) and Other Gene
Amplification Markets for 2003, 2008 & 2012 III-30

4e. Rest of Europe III-31
A.Market Analysis III-31
Product Launches III-31
Strategic Corporate Development III-32
Key Players III-33
Roche Diagnostics (Switzerland) III-33
QIAGEN N.V (Netherlands) III-33
B.Market Analytics III-34
Table 37: Rest of Europe Market for Gene Amplification
Technologies - Recent Past, Current & Future Market Analysis
by Segment for Polymerase Chain Reaction (PCR) and Other
Gene Amplification Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2000 through
2010 (includes corresponding Graph/Chart) III-34

Table 38: Rest of Europe Long-term Projections for Gene
Amplification Technologies by Segment - Polymerase Chain
Reaction (PCR) and Other Gene Amplification Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2011 through 2015 (includes corresponding
Graph/Chart) III-35

Table 39: Rest of Europe 10-Year Perspective for Gene
Amplification Technologies by Segment - Percentage Breakdown
of Dollar Sales for Polymerase Chain Reaction (PCR) and
Other Gene Amplification Markets for 2003, 2008 & 2012 III-35

5. Rest of World III-36
A.Market Analysis III-36
Product Launch III-36
Strategic Corporate Developments III-36
B.Market Analytics III-37
Table 40: Rest of World Market for Gene Amplification
Technologies - Recent Past, Current & Future Market Analysis
by Segment for Polymerase Chain Reaction (PCR) and Other
Gene Amplification Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2000 through
2010 (includes corresponding Graph/Chart) III-37

Table 41: Rest of World (*) Long-term Projections for Gene
Amplification Technologies by Segment - Polymerase Chain
Reaction (PCR) and Other Gene Amplification Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2011 through 2015 (includes corresponding
Graph/Chart) III-38

Table 42: Rest of World 10-Year Perspective for Gene
Amplification Technologies by Segment - Percentage Breakdown
of Dollar Sales for Polymerase Chain Reaction (PCR) and
Other Gene Amplification Markets for 2003, 2008 & 2012 III-38

IV. COMPETITIVE LANDSCAPE

RELATED REPORTS

World Agricultural and Environmental Diagnostics Market

$ 3 950
October 2008
423 pages

This report analyzes the worldwide markets for Agricultural and Environmental Diagnostics in Millions of US$. The specific product segments analyzed are Food Residue Diagnostics, Environmental Testing, and Microbiology Testing. The report provides separate comprehensive analytics for the US, Canada, ...

Industries : Biotechnology

World Biochips Market

$ 3 950
October 2008
335 pages

This report analyzes the worldwide markets for Biochips in Millions of US$. The specific product segments analyzed are DNA Chips, Protein Chips, and Lab Chips. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest of World. Annual forecasts are provided fo ...

Industries : Biotechnology

China Industrial Biotechnology

$ 4 000
August 2006
108 pages

China Industrial Biotechnology provides an in-depth look at China’s explosive growth in research and commercialization of white biotech. This report is essential for understanding China’s industrial biotech players, trends, government actions, research & development, and markets.China Industrial ...

Industries : Biotechnology | Countries : China

China Bio-services

$ 2 000
May 2006
90 pages

China Bio-services is an essential resource for biotechnology and pharmaceutical companies aiming to increase R&D productivity and reduce costs through outsourcing to bio-services companies. This fully updated report includes industry analysis and provides information on 74 Chinese and joint venture ...

Industries : Biotechnology | Countries : China

China Biotech 2008

$ 500
January 2008
88 pages

China Biotech 2008 provides an in depth look at biotechnology R&D in China, industry statistics and indicators, and an authoritative directory of biotechnology companies. This report is essential for understanding China’s emerging innovators, identifying potential clients and partners, and staying ...

Industries : Biotechnology | Countries : China

World Gene Therapy Market

$ 3 950
October 2008
293 pages

This report analyzes the world market for Gene Therapy in Millions of US$. Annual forecasts are provided for the global market for the period of 2007 through 2015. The report profiles 100 companies including many key and niche players worldwide such as AnGes MG Inc., Cell Genesys, GenVec, Genzyme Co ...

Industries : Biotechnology

World Biotechnology Reagents Market

$ 3 950
October 2008
759 pages

This report analyzes the worldwide markets for Biotechnology Reagents in Millions of US$. The specific product segments analyzed are Cell/Tissue Culture Reagents, DNA Sequencing/Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagent ...

Industries : Biotechnology

The Epigenetics Healthcare R&D, Products and Commercial Implications

$ 1 495
January 2009
148 pages

This report presents information about the quickly emerging worldwide epigenetics market. This important life science market includes key product areas that will have a powerful impact on current and future healthcare. This broad and high-level report takes a business focus and analyzes epigenetic ...

Industries : Biotechnology

Top-10 Biotech Companies - Market Outlook, 2008-2023

$ 2 501
February 2009
157 pages

The biotechnology industry is a major growth area in the global healthcare market, one upon which many companies are placing their hopes. Due to developments in monoclonal antibodies, genomics and proteomics - amongst others - the biotechnology market has experienced great expansion since its emerge ...

Industries : Biotechnology

Negotiating the Emerging Biosimilars Landscape: Key developments in the regulatory environment

$ 3 835
February 2009
224 pages

Negotiating the Emerging Biosimilars Landscape Key developments in the regulatory environment As regulatory obstacles to biosimilars development have become increasingly resolved, a growing number of opportunities have been created for generics companies in the biopharmaceutical marke ...

Industries : Biotechnology

24/7 Customer Service

Contact Shadi now !

(866) 682 9815
Ask Shadi by email

Related industries

Biotechnology Industry

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.